IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Why VP Kamala Harris’ Visit to Planned Parenthood Is So Historic – Even For Dems

    04:43
  • Supreme Court: self-preservation at democracy’s expense, says Kermit Roosevelt

    04:11
  • Joy Reid: Civil Rights icon Myrlie Evers’ sense of 'disappointment' at the slow progress of civil rights

    11:20
  • The long history of U.S. intervention in Haiti 

    04:54
  • Gaza entrepreneurs want youth to play a role in Gaza’s future

    11:33
  • Exploring Haitian culture and the American Dream with 'American Street' by Ibi Zoboi

    10:18
  • Nikole Hannah-Jones on How an American ideal got hijacked

    11:33
  • Wife of Russian political prisoner: Russian people 'enraged' at Putin after years of 'being lied to'

    11:34
  • ‘A system of overseers’: Diluting progressive prosecutors & the voters who elect them

    11:51
  • ‘Righteous rage’: How female rage translates to political progress

    10:54
  • Rep. Crockett blasts ‘tone deaf’ Republican response to State of the Union

    10:30
  • ‘Very unusual’: These 3 GOP Senators say they won't vote for Trump in November

    03:04
  • Barge set for Gaza carrying nearly 200 tons of rice and flour

    04:08
  • Biden campaign releases new ad focusing on age

    02:13
  • Formerly homeless man is a voice for his community in Boston

    07:34
  • Brand new report reveals widening voter participation gap due to gutting of Voting Rights Act

    08:13
  • Uncommitted vote in Michigan 'doing Biden a favor' by sounding alarm on Gaza policy

    11:20
  • Velshi: A protest vote in a primary election is useful. But don’t play with fire in November

    05:14
  • Israelis eyeing start of Ramadan for cease-fire but negotiations over hostages continue

    04:28
  • ‘This is her Achilles Heel’: Why Haley’s decision on Trump endorsement could be revealing

    10:00

Dr. Peter Hotez: ‘The FDA and CDC really had no choice’ but to pause Johnson & Johnson vaccine

03:16

Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine, joins Ali Velshi to discuss the "pause" on the Johnson & Johnson vaccine in the United States after the discovery of 6 rare cases of blood clotting in women who were immunized with the shot. The goal, says Hotez, is to identify a specific group who might be at higher risk, and that requires a little time. “Even though the U.S. Has other options, many countries don't. For many countries, all they have are the J & J, AstraZeneca vaccine and the Russian Sputnik V vaccine,” all of which are non-mNRA and have the potential to behave similarly. Says Hotez, “It is critical to sort this out not only to protect American citizens, but to protect the world.”